SOMERSET, N.J.--(BUSINESS WIRE)--Catalent Pharma Solutions, Inc., one of the leading providers of advanced technologies and outsourced services to the global pharmaceutical, biotechnology and consumer health industry announced its financial results for its second fiscal quarter ended December 31, 2007. Catalent recognized net revenue for the three months then ended of $464.0 million and EBITDA from continuing operations of $44.8 million for the same period after giving effect to the Acquisition and related purchase method of accounting adjustments. EBITDA and Adjusted EBITDA as detailed in the attached schedules for the twelve months ended December 31, 2007 were $57.1 million and $338.9 million, respectively. EBITDA and Adjusted EBITDA are defined below under “Non-GAAP Financial Matters”.
